CBD of Denver Wants to Provide an Update on Progress with the Company and Additional Corporate Updates
Denver, Colorado--(Newsfile Corp. - August 7, 2023) - CBD of Denver (OTC Pink: CBDD) would like to update its shareholders...
Denver, Colorado--(Newsfile Corp. - August 7, 2023) - CBD of Denver (OTC Pink: CBDD) would like to update its shareholders...
Charlotte, North Carolina--(Newsfile Corp. - August 7, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the...
Revenue optimization and compliance leader included in Fortune’s 2023 Best Workplaces for Millennials listSAN MATEO, Calif.--(BUSINESS WIRE)--Fortune Media and Great...
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting,...
Masimo PSi, a Processed EEG Parameter, “Better Captured” Changes in Brain State Compared to Other Assessment MethodsIRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ:...
Device Will Be Critical in Aiding Patients Suffering From COPDMCALLEN, TX / ACCESSWIRE / August 7, 2023 / Accuhealth, a...
Achieves 20% Revenue Surge in Key Markets, Demonstrating Success of Strategic Initiatives and Growing Market DemandMIRAMAR, FL / ACCESSWIRE /...
A significant proportion of patients undergoing cancer therapy experience diarrhea, which has the potential to cause dehydration and non-adherence to...
BBS-Bioactive Bone Substitutes Plc, Company announcement, management transactions, 7 August 2023 at 16.00 (EEST) BBS-Bioactive Bone Substitutes Oyj - Managers'...
BBS-Bioactive Bone Substitutes Plc, Company announcement, management transactions, 7 August 2023 at 16.00 (EEST) BBS-Bioactive Bone Substitutes Oyj - Managers'...
BBS-Bioactive Bone Substitutes Plc, Company announcement, management transactions, 7 August 2023 at 16.00 (EEST) BBS-Bioactive Bone Substitutes Oyj - Managers'...
PALO ALTO, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the...
Cash of approximately $18.0 million as of June 30, 2023, provides ample runway to fund operations into Q3 2024; anticipated...
Review Includes Interactive Links to Company’s Major AnnouncementsMIAMI, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL)...
Data presented at The Autoimmunity Conference hosted by the Federation of American Societies for Experimental Biology (FASEB) GRI-0803 in development...
Real-world study that explored the healthcare utilization resource utilization among patients receiving GIMOTI with and without prior treatment with oral...
Offering includes participation from both new and existing healthcare-dedicated investorsProceeds extend the company’s cash runway into the fourth quarter of...
New migraine data builds on prior clinical studies in depression Migraine trial results Migraine trial results Depression trial results Depression...
LAWRENCEVILLE, N.J., Aug. 07, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing non-viral...
FREMONT, CA, Aug. 07, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company...